Glen Eagle Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.5M Sell
112,443
-783
-0.7% -$182K 3.85% 4
2025
Q4
$23.4M Sell
113,226
-942
-0.8% -$186K 3.19% 8
2025
Q3
$21.2M Buy
114,168
+6,448
+6% +$1.1M 2.94% 8
2025
Q2
$16.5M Buy
107,720
+1,336
+1% +$205K 2.53% 9
2025
Q1
$17.6M Sell
106,384
-500
-0.5% -$78.2K 2.92% 8
2024
Q4
$15.5M Sell
106,884
-565
-0.5% -$87.6K 2.56% 9
2024
Q3
$17.4M Sell
107,449
-3,557
-3% -$567K 2.94% 8
2024
Q2
$16.2M Sell
111,006
-5,552
-5% -$826K 2.97% 8
2024
Q1
$18.4M Sell
116,558
-2,654
-2% -$422K 3.5% 5
2023
Q4
$18.7M Sell
119,212
-512
-0.4% -$78.5K 3.88% 5
2023
Q3
$18.6M Buy
119,724
+1,242
+1% +$205K 4.32% 3
2023
Q2
$19.6M Buy
118,482
+2,037
+2% +$329K 4.52% 3
2023
Q1
$18M Buy
116,445
+3,447
+3% +$557K 4.53% 2
2022
Q4
$20M Buy
112,998
+914
+0.8% +$158K 5.45% 1
2022
Q3
$18.3M Sell
112,084
-5,069
-4% -$858K 5.32% 1
2022
Q2
$20.8M Buy
117,153
+5,237
+5% +$933K 5.64% 1
2022
Q1
$19.8M Sell
111,916
-548
-0.5% -$93.2K 5.18% 2
2021
Q4
$19.2M Buy
112,464
+1,211
+1% +$198K 5% 2
2021
Q3
$18M Buy
111,253
+8,871
+9% +$1.51M 5.2% 2
2021
Q2
$16.9M Buy
102,382
+982
+1% +$163K 5.24% 2
2021
Q1
$16.7M Buy
101,400
+1,461
+1% +$236K 5.82% 1
2020
Q4
$15.7M Buy
99,939
+1,546
+2% +$228K 6.19% 1
2020
Q3
$14.6M Buy
98,393
+2,428
+3% +$359K 6.56% 1
2020
Q2
$13.5M Buy
95,965
+81,737
+574% +$11.9M 6.93% 1
2020
Q1
$1.87M Buy
14,228
+74
+0.5% +$10.5K 1.31% 16
2019
Q4
$2.06M Sell
14,154
-1,559
-10% -$211K 1.1% 19
2019
Q3
$2.03M Sell
15,713
-1,068
-6% -$141K 1.34% 15
2019
Q2
$2.32M Sell
16,781
-77
-0.5% -$10.7K 1.59% 12
2019
Q1
$2.36M Buy
16,858
+91
+0.5% +$12.2K 1.71% 9
2018
Q4
$2.16M Sell
16,767
-34
-0.2% -$4.74K 1.82% 9
2018
Q3
$2.32M Sell
16,801
-1,013
-6% -$135K 1.66% 12
2018
Q2
$2.16M Sell
17,814
-99
-0.6% -$12.4K 1.69% 10
2018
Q1
$2.3M Sell
17,913
-133
-0.7% -$18K 1.89% 7
2017
Q4
$2.52M Buy
18,046
+1,470
+9% +$205K 2.19% 7
2017
Q3
$2.16M Sell
16,576
-3,629
-18% -$481K 2.01% 7
2017
Q2
$2.67M Buy
20,205
+1,264
+7% +$161K 2.14% 7
2017
Q1
$2.36M Buy
18,941
+419
+2% +$50.1K 2.03% 7
2016
Q4
$2.13M Buy
+18,522
New +$2.14M 1.92% 7

Other funds holding JNJ

Glen Eagle Advisors's JNJ Position: Q1 2026 in Review

Glen Eagle Advisors reduced its Johnson & Johnson (JNJ) stake by 0.69% in Q1 2026, selling an estimated $182K and leaving 112,443 shares worth $27.5M. The position accounts for 3.85% of the portfolio, ranked #4.

Glen Eagle Advisors first reported a position in JNJ in Q4 2016 and has held it in 38 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Glen Eagle Advisors held 112,443 shares of Johnson & Johnson worth $27.5M as of Q1 2026.
  • Glen Eagle Advisors sold 783 Johnson & Johnson shares in Q1 2026, an estimated $182K.
  • Johnson & Johnson made up 3.85% of Glen Eagle Advisors's portfolio in Q1 2026, its #4 holding.
  • Glen Eagle Advisors first reported a position in Johnson & Johnson in Q4 2016 and has held it in 38 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.